Scios Nova Inc. deal

Under the revised agreement, Pfizer will provide undisclosed time- and event-based milestones in exchange for reduced royalties to SCIO and undisclosed changes in the manufacturing and marketing terms.

SCIO said the amendment, which calls for its decreased participation in marketing and manufacturing, and an increased participation in development, reflects the company's deemphasis of the chronic/acute care market. ...